MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy (Q38839830)

6 September 2017

MAPK/ERK signaling pathway-induced hyper-O-GlcNAcylation enhances cancer malignancy (English)

1 reference

6 September 2017

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Xinling Zhang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jieqiong Qi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Hui Shan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Wengong Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Yuchao Gu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

publication date

29 August 2015

1 reference

6 September 2017

10

1 reference

Molecular and Cellular Biochemistry

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

410

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

101-110

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26318312%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11010-015-2542-8

1 June 2020

exact match

0 references

cites work

AKT/PKB signaling: navigating downstream

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Dynamic O-GlcNAc modification regulates CREB-mediated gene expression and memory formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Regulation of AMPA receptor trafficking by O-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Cell signaling, the essential role of O-GlcNAc!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Snail1 is stabilized by O-GlcNAc modification in hyperglycaemic condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Coordinating ERK/MAPK signalling through scaffolds and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Effects of active MEK1 expression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

MAP kinase signalling pathways in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Targeting the mitogen-activated protein kinase cascade to treat cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Negative regulation of MAPKK by phosphorylation of a conserved serine residue equivalent to Ser212 of MEK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Nuclear organization and chromatin dynamics--Sp1, Sp3 and histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

O-linked β-N-acetylglucosaminylation (O-GlcNAcylation) in primary and metastatic colorectal cancer clones and effect of N-acetyl-β-D-glucosaminidase silencing on cell phenotype and transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Targeting RAS signalling pathways in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Signal transducer and activator of transcription 5b (Stat5b) serine 193 is a novel cytokine-induced phospho-regulatory site that is constitutively activated in primary hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

MYC on the path to cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Stat proteins and oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

STAT1 acts as a tumor promoter for leukemia development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Stage-associated dynamic activity profile of transcription factors in nasopharyngeal carcinoma progression based on protein/DNA array analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Targeting CREB for cancer therapy: friend or foe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

High levels of phosphorylated c-Jun, Fra-1, Fra-2 and ATF-2 proteins correlate with malignant phenotypes in the multistage mouse skin carcinogenesis model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Ets proteins in biological control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

The mutational landscape of lethal castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Integrative molecular concept modeling of prostate cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Novel genes associated with malignant melanoma but not benign melanocytic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Gene expression patterns in human liver cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Gene expression profiling of advanced-stage serous ovarian cancers distinguishes novel subclasses and implicates ZEB2 in tumor progression and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

GlcNAcylation plays an essential role in breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-015-2542-8

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab

21 January 2018

1 reference

12 December 2020

CBP/p300 in cell growth, transformation, and development

1 reference

12 December 2020

O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells

1 reference

12 December 2020

Gene-expression profiles predict survival of patients with lung adenocarcinoma

1 reference

12 December 2020

Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors

1 reference

12 December 2020

AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation

1 reference

12 December 2020

Gene signatures of progression and metastasis in renal cell cancer

1 reference

12 December 2020

p300/CBP proteins: HATs for transcriptional bridges and scaffolds

1 reference

12 December 2020

Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma

1 reference

12 December 2020

p300 in prostate cancer proliferation and progression.

1 reference

12 December 2020

Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas

1 reference

12 December 2020